Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Role of modern immunotherapy in gastrointestinal malignancies: a review of current clinical progressMyint, Zin W ; Goel, GauravJournal of hematology and oncology, 2017-04, Vol.10 (1), p.86-86, Article 86 [Periódico revisado por pares]England: BioMed CentralTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Androgen Receptor Signaling in Prostate Cancer and Therapeutic StrategiesJacob, Aasems ; Raj, Rishi ; Allison, Derek B ; Myint, Zin WCancers, 2021-10, Vol.13 (21), p.5417 [Periódico revisado por pares]Switzerland: MDPI AGTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
The Role of Anticoagulation in Tumor Thrombus Associated with Renal Cell Carcinoma: A Literature ReviewWilliams, Chelsey M ; Myint, Zin WCancers, 2023-11, Vol.15 (22), p.5382 [Periódico revisado por pares]Switzerland: MDPI AGTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Case report: Enfortumab vedotin induced refractory DKA and multi organ failure - a rare fatal adverse eventKapoor, Astha Koolwal ; Ellis, Carleton S ; Pandey, Deepali ; Allison, Derek B ; Myint, Zin WFrontiers in oncology, 2024-02, Vol.14, p.1332478 [Periódico revisado por pares]Switzerland: Frontiers Media S.ATexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Bone Fracture Incidence After Androgen Deprivation Therapy-Investigational Agents: Results From Cancer Therapy Evaluation Program-Sponsored Early Phase Clinical Trials 2006–2013Myint, Zin W. ; Kunos, Charles A.Frontiers in oncology, 2020-07, Vol.10, p.1125-1125 [Periódico revisado por pares]Frontiers Research FoundationTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
A single arm phase II study of bone-targeted Sn-117 m-DTPA in symptomatic castration-resistant prostate cancer with skeletal metastasesMyint, Zin W ; El Khouli, Riham ; Lemieux, Bryan ; Yan, Donglin ; St Clair, William H ; Liu, Xiaoqi ; Kunos, Charles ABMC cancer, 2022-04, Vol.22 (1), p.415-9, Article 415 [Periódico revisado por pares]England: BioMed Central LtdTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Case Report: Safety and Efficacy of Enfortumab Vedotin in a Patient With Metastatic Urothelial Carcinoma Undergoing Peritoneal DialysisCollette, Kaylyn R ; Myint, Zin W ; Parasramka, Saurabh V ; Ellis, Carleton SFrontiers in oncology, 2022-05, Vol.12, p.892793 [Periódico revisado por pares]Switzerland: Frontiers Media S.ATexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Clinical and Genomic Features of Patients with Renal Cell Carcinoma and Advanced Chronic Kidney Disease: Analysis of a Multi-Institutional DatabaseEule, Corbin J ; Hu, Junxiao ; Hedges, Dale ; Jani, Alkesh ; Pshak, Thomas ; Manley, Brandon J ; Sanchez, Alejandro ; Dreicer, Robert ; Myint, Zin W ; Zakharia, Yousef ; Lam, Elaine TCancers, 2024-05, Vol.16 (10), p.1920 [Periódico revisado por pares]Switzerland: MDPI AGTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
A Phase I Dose Escalation and Expansion Study of Epidiolex (Cannabidiol) in Patients with Biochemically Recurrent Prostate CancerMyint, Zin W ; St Clair, William H ; Strup, Stephen E ; Yan, Donglin ; Li, Ning ; Allison, Derek B ; McLouth, Laurie E ; Ellis, Carleton S ; Wang, Peng ; James, Andrew C ; Hensley, Patrick J ; Otto, Danielle E ; Arnold, Susanne M ; DiPaola, Robert S ; Kolesar, Jill MCancers, 2023-04, Vol.15 (9), p.2505 [Periódico revisado por pares]Switzerland: MDPI AGTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Adjuvant PD-1 and PD-L1 Inhibitors and Relapse-Free Survival in Cancer Patients: The MOUSEION-04 StudyRizzo, Alessandro ; Mollica, Veronica ; Marchetti, Andrea ; Nuvola, Giacomo ; Rosellini, Matteo ; Tassinari, Elisa ; Molina-Cerrillo, Javier ; Myint, Zin W ; Buchler, Tomas ; Monteiro, Fernando Sabino Marques ; Grande, Enrique ; Santoni, Matteo ; Massari, FrancescoCancers, 2022-08, Vol.14 (17), p.4142 [Periódico revisado por pares]Basel: MDPI AGTexto completo disponível |